President Trump Signs SCD Treatment Act into Law

more funds to flow into research for improved quality of life, cure ….

On December 11, 2018, the US Congress passed the bi-partisan Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018. This legislation authorizes a program within the Centers for Disease Control and Prevention (CDC) that will allow states, academic institutions, and non-profit organizations to apply for grants to gather information on the prevalence of sickle cell disease (SCD) and the health outcomes, complications, and treatment that people with SCD experience.

The Act also re-authorizes SCD treatment grants awarded by the Health Resources and Services Administration (HRSA), which will help to improve access to care and quality of care for individuals with SCD.

Leave Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

grandpashabet girişgrandpashabet girişdeneme bonusudeneme bonusu veren bahis sitelerideneme bonusu 2026grandpashabet girişGrandpashabetgrandpashabetgrandpashabet deneme bonusugrandpashabet deneme bonusudeneme bonusuGrandpashabetgrandpashabet girişgrandpashabetgrandpashabet güncel girişbahis siteleribahis siteleriGrandpashabet girişjojobetjojobet girişjojobetjojobet girişjojobet girişjojobetjojobet